Article
Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC).
Oncotarget - 21 Feb 2017
Zhu Qianqian, Sun Yanan, Cui Yingying, Ye Ke, Yang Chengliang, Yang Daoke, Ma Jie, Liu Xiao, Yu Jinming, Ge Hong
Abstract excerpt
This study compared treatment outcomes between TKI monotherapy and TKI administration combined with brain radiotherapy (TKI + RT) in 133 non-small cell lung cancer (NSCLC) patients with brain metastasis (BM). We also evaluated the association of different epidermal growth factor receptor (EGFR) mutation subtypes with treatment outcome. To screen for potential variables affecting cranial progression free survival...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.